Cargando…

Lower serum 25-hydroxycholecalciferol is associated with depressive symptoms in older adults in Southern Brazil

BACKGROUND: Older adults are one of the most susceptible populations to depression, especially those living in low- and middle-income countries. As well, they are also considering a risk group for vitamin D deficiency. Low serum vitamin D has been associated with an increased risk of brain neuropsyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceolin, Gilciane, Matsuo, Luísa Harumi, Confortin, Susana Cararo, D’Orsi, Eleonora, Rieger, Débora Kurrle, Moreira, Júlia Dubois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666456/
https://www.ncbi.nlm.nih.gov/pubmed/33189154
http://dx.doi.org/10.1186/s12937-020-00638-5
_version_ 1783610130737135616
author Ceolin, Gilciane
Matsuo, Luísa Harumi
Confortin, Susana Cararo
D’Orsi, Eleonora
Rieger, Débora Kurrle
Moreira, Júlia Dubois
author_facet Ceolin, Gilciane
Matsuo, Luísa Harumi
Confortin, Susana Cararo
D’Orsi, Eleonora
Rieger, Débora Kurrle
Moreira, Júlia Dubois
author_sort Ceolin, Gilciane
collection PubMed
description BACKGROUND: Older adults are one of the most susceptible populations to depression, especially those living in low- and middle-income countries. As well, they are also considering a risk group for vitamin D deficiency. Low serum vitamin D has been associated with an increased risk of brain neuropsychiatry disorders. We aimed to investigate the association between serum 25-hydroxycholecalciferol concentrations and depressive symptoms in adults aged 60 years and over from southern Brazil. METHODS: A cross-sectional analysis was performed using data collected during 2013–2014 from the populational-based longitudinal EpiFloripa Aging Study (n = 1197). Serum 25-hydroxycholecalciferol concentrations were analyzed and classified according to the Endocrine Society reference values [sufficiency (≥ 30 ng/mL), insufficiency (21–29 ng/mL), and deficiency (≤ 20 ng/mL)]. Depressive symptoms were evaluated using the Geriatric Depression Scale (15-item GDS). Logistic regression was performed to assess depressive symptoms in each vitamin D category. The analysis was adjusted for sex, age, skin color, family income, leisure-time physical activities, social or religious groups attendance, morbidities, cognitive impairment, and dependence in activities of daily living. RESULTS: A total of 557 participants with complete data for exposure and outcome were enrolled in the analysis. Most of the sample participants were female (63.1%), age-range 60–69 years (42.2%), white skin color (85.1%), and vitamin D serum level samples were collected in autumn (50.7%). Depressive symptoms were present in 15.8% of the participants, and the prevalence was higher in individuals classified as deficient in vitamin D (23.2, 95% confidence interval [CI] = 15.6;32.9) and insufficiency (17.2, 95%CI = 11.0;25.9). The crude analysis showed that vitamin D deficient participants had 3.08 (CI = 1.53;6.20) times higher odds to present depressive symptoms compared to vitamin D sufficiency. After adjusting, the association was maintained [OR 2.27 (95%CI = 1.05;4.94). CONCLUSIONS: Serum 25-hydroxycholecalciferol deficiency was positively associated with depressive symptoms in older adults from southern Brazil.
format Online
Article
Text
id pubmed-7666456
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76664562020-11-16 Lower serum 25-hydroxycholecalciferol is associated with depressive symptoms in older adults in Southern Brazil Ceolin, Gilciane Matsuo, Luísa Harumi Confortin, Susana Cararo D’Orsi, Eleonora Rieger, Débora Kurrle Moreira, Júlia Dubois Nutr J Research BACKGROUND: Older adults are one of the most susceptible populations to depression, especially those living in low- and middle-income countries. As well, they are also considering a risk group for vitamin D deficiency. Low serum vitamin D has been associated with an increased risk of brain neuropsychiatry disorders. We aimed to investigate the association between serum 25-hydroxycholecalciferol concentrations and depressive symptoms in adults aged 60 years and over from southern Brazil. METHODS: A cross-sectional analysis was performed using data collected during 2013–2014 from the populational-based longitudinal EpiFloripa Aging Study (n = 1197). Serum 25-hydroxycholecalciferol concentrations were analyzed and classified according to the Endocrine Society reference values [sufficiency (≥ 30 ng/mL), insufficiency (21–29 ng/mL), and deficiency (≤ 20 ng/mL)]. Depressive symptoms were evaluated using the Geriatric Depression Scale (15-item GDS). Logistic regression was performed to assess depressive symptoms in each vitamin D category. The analysis was adjusted for sex, age, skin color, family income, leisure-time physical activities, social or religious groups attendance, morbidities, cognitive impairment, and dependence in activities of daily living. RESULTS: A total of 557 participants with complete data for exposure and outcome were enrolled in the analysis. Most of the sample participants were female (63.1%), age-range 60–69 years (42.2%), white skin color (85.1%), and vitamin D serum level samples were collected in autumn (50.7%). Depressive symptoms were present in 15.8% of the participants, and the prevalence was higher in individuals classified as deficient in vitamin D (23.2, 95% confidence interval [CI] = 15.6;32.9) and insufficiency (17.2, 95%CI = 11.0;25.9). The crude analysis showed that vitamin D deficient participants had 3.08 (CI = 1.53;6.20) times higher odds to present depressive symptoms compared to vitamin D sufficiency. After adjusting, the association was maintained [OR 2.27 (95%CI = 1.05;4.94). CONCLUSIONS: Serum 25-hydroxycholecalciferol deficiency was positively associated with depressive symptoms in older adults from southern Brazil. BioMed Central 2020-11-14 /pmc/articles/PMC7666456/ /pubmed/33189154 http://dx.doi.org/10.1186/s12937-020-00638-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ceolin, Gilciane
Matsuo, Luísa Harumi
Confortin, Susana Cararo
D’Orsi, Eleonora
Rieger, Débora Kurrle
Moreira, Júlia Dubois
Lower serum 25-hydroxycholecalciferol is associated with depressive symptoms in older adults in Southern Brazil
title Lower serum 25-hydroxycholecalciferol is associated with depressive symptoms in older adults in Southern Brazil
title_full Lower serum 25-hydroxycholecalciferol is associated with depressive symptoms in older adults in Southern Brazil
title_fullStr Lower serum 25-hydroxycholecalciferol is associated with depressive symptoms in older adults in Southern Brazil
title_full_unstemmed Lower serum 25-hydroxycholecalciferol is associated with depressive symptoms in older adults in Southern Brazil
title_short Lower serum 25-hydroxycholecalciferol is associated with depressive symptoms in older adults in Southern Brazil
title_sort lower serum 25-hydroxycholecalciferol is associated with depressive symptoms in older adults in southern brazil
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666456/
https://www.ncbi.nlm.nih.gov/pubmed/33189154
http://dx.doi.org/10.1186/s12937-020-00638-5
work_keys_str_mv AT ceolingilciane lowerserum25hydroxycholecalciferolisassociatedwithdepressivesymptomsinolderadultsinsouthernbrazil
AT matsuoluisaharumi lowerserum25hydroxycholecalciferolisassociatedwithdepressivesymptomsinolderadultsinsouthernbrazil
AT confortinsusanacararo lowerserum25hydroxycholecalciferolisassociatedwithdepressivesymptomsinolderadultsinsouthernbrazil
AT dorsieleonora lowerserum25hydroxycholecalciferolisassociatedwithdepressivesymptomsinolderadultsinsouthernbrazil
AT riegerdeborakurrle lowerserum25hydroxycholecalciferolisassociatedwithdepressivesymptomsinolderadultsinsouthernbrazil
AT moreirajuliadubois lowerserum25hydroxycholecalciferolisassociatedwithdepressivesymptomsinolderadultsinsouthernbrazil